Medical researchers have found that low doses of an intravenous anesthetic known as Ketamine may offer relief from the debilitating pain of Complex Regional Pain Syndrome (CRPS). Their findings have been published in the Journal of Pain Medicine. What is IV Ketamine Infusion Therapy?…
Recently, the American Society of Regional Anesthesia and Pain Medicine selected Dr. Michael Stanton-Hicks as its 2017 John J. Bonica Lecture Award winner. Having been called a giant in the management of complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD) because of his extensive contributions to…
When 15-year-old Nazair (Naz) Jones woke up on November 5, 2011, he could not move. Then after years of persistent pain, complete loss of control of the use of his limbs, and the loss of 50 pounds, the once-healthy, gifted athlete was diagnosed with complex…
Thinking of taking a trip overseas? For those who suffer from complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), this can be a painful proposition. Extended travel is particularly difficult for those dealing with chronic pain, given the shrinking legroom and lack of flexibility airline seats…
Medical marijuana has been approved for use in 23 states, and the law in Illinois allows patients with one of 40 specified medical conditions, including complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), to get a doctor’s recommendation to buy marijuana from one of the state’s…
Chronic pain has been the subject of several recent sources of information, such as the proposed opioid guidelines released recently by the Centers for Disease Control and Prevention (CDC), and an article published in the November 26th edition New England Journal of Medicine stating that…
Articles surrounding complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD) often describe the disorder as “painful,” “misunderstood,” and “difficult to treat” for one very important reason: like fibromyalgia, low back pain, or even a simple headache, CRPS/RSD is a human condition without reliable animal models, and…
A Pittsburg-based drug development company has received U.S. Food and Drug Administration (FDA) approval for phase 3 clinical trials of a product to treat severe, persistent pain. The medication, T-121, is being developed by Thar Pharmaceuticals and is expected to enter the market by 2019.…
Although the pain suffered is extremely real to a sufferer of complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), it can be very hard to prove, particularly in court. Some of the difficulties that CRPS/RSD sufferers may encounter if they file a personal injury claim to…
The average CRPS/RSD patient sees five and 10 doctors before he can get a diagnosis, and many physicians have little or no knowledge or understanding of the condition. Some question whether or not it even exists. What is CRPS/RSD? Complex regional pain syndrome/reflex sympathetic dystrophy…
injured or have lost loved ones due to the negligent actions
of others deserve a voice.”